Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial

John W. Ostrominski, Scott D. Solomon, Brian Claggett et al.|Circulation|2023

Cited by 20